MK
Mahesh Kantilal Shah
About Mahesh Kantilal Shah
Data last updated:
Mahesh Kantilal Shah is a Director at Skites Pharma Private Limited (since 2018), Director at S Kant India Private Limited (since 2023) and Director at Ashok Gnxt Pharma Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma and Home Appliances. The 4 current companies with reported revenue have a combined latest revenue of ₹771 Cr; the largest is Skites Pharma Private Limited at ₹661 Cr (FY 2025). Earlier, Mahesh Kantilal Shah was a Director at S Kant Healthcare Limited (2001–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Skites Pharma Private Limited U24304MH2017PTC292537 | Director | 13 Feb 2018 | 2017 | ₹661 Cr (FY 2025) | Active |
 S Kant India Private Limited U24290MH2023PTC397388 | Director | 11 Jan 2023 | 2023 | ₹73.61 Cr (FY 2025) | Active |
| Ashok Gnxt Pharma Private Limited U51909GJ2019PTC107421 | Director | 26 Oct 2021 | 2019 | ₹34.06 Cr (FY 2025) | Active |
| Skites Retail Private Limited U52399MH2021PTC354483 | Director | 03 Feb 2021 | 2021 | ₹2.62 Cr (FY 2025) | Active |
| Shroff Pharma Llp AAC-6816 | Partner | 01 Aug 2019 | 2014 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 S Kant Healthcare Limited U24230MH1996PLC098246 | Director | 01 Apr 2001 | 1996 | ₹452 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mahesh Kantilal Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rohan Mahesh Shah | 02867201 | Skites Pharma Private Limited , S Kant India Private Limited and 3 more | Director |
| Samir Jayantilal Shah | 00157396 | Skites Pharma Private Limited , S Kant India Private Limited and 3 more | Director |
| Yusuke Kumaki | 11097156 | Skites Pharma Private Limited , S Kant India Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahesh Kantilal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahesh Kantilal Shah
Mahesh Kantilal Shah currently holds 5 directorships: Skites Pharma Private Limited (Director, since 13 Feb 2018, revenue ₹661 Cr (FY 2025)); S Kant India Private Limited (Director, since 11 Jan 2023, revenue ₹73.61 Cr (FY 2025)); Ashok Gnxt Pharma Private Limited (Director, since 26 Oct 2021, revenue ₹34.06 Cr (FY 2025)); Skites Retail Private Limited (Director, since 03 Feb 2021, revenue ₹2.62 Cr (FY 2025)); Shroff Pharma Llp (Partner, since 01 Aug 2019).
Mahesh Kantilal Shah was first appointed on 01 Apr 2001 as Director at S Kant Healthcare Limited. The most recent appointment on record is 11 Jan 2023 at S Kant India Private Limited.
The 4 current companies of Mahesh Kantilal Shah that report revenue have a combined latest revenue of ₹771 Cr: Skites Pharma Private Limited ₹661 Cr (FY 2025); S Kant India Private Limited ₹73.61 Cr (FY 2025); Ashok Gnxt Pharma Private Limited ₹34.06 Cr (FY 2025); Skites Retail Private Limited ₹2.62 Cr (FY 2025).
Mahesh Kantilal Shah held 1 earlier board appointment: S Kant Healthcare Limited (Director, 01 Apr 2001 to 29 Sep 2022).
The current boards of Mahesh Kantilal Shah's companies include Rohan Mahesh Shah (Skites Pharma Private Limited), Samir Jayantilal Shah (Skites Pharma Private Limited), Yusuke Kumaki (Skites Pharma Private Limited).